Publicaciones en las que colabora con Javier de la Serna Torroba (11)

2019

  1. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster after Autologous Stem Cell Transplantation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 322, Núm. 2, pp. 123-133

2015

  1. Outcome of graft failure after allogeneic stem cell transplant: Study of 89 patients

    Leukemia and Lymphoma, Vol. 56, Núm. 3, pp. 656-662

2011

  1. Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

    Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16

2010

  1. Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: Long-term follow-up from two prospective multicenter trials

    Haematologica, Vol. 95, Núm. 7, pp. 1176-1182

2002

  1. Myeloablative treatments for multiple myeloma: Update of a comparative study of different regimens used in patients from the Spanish Registry for transplantation in multiple myeloma

    Leukemia and Lymphoma, Vol. 43, Núm. 1, pp. 67-74

2001

  1. Allogeneic transplantation of CD34+ -selected cells from peripheral blood in patients with myeloid malignancies in early phase: A case control comparison with unmodified peripheral blood tranplantation

    Bone Marrow Transplantation, Vol. 28, Núm. 4, pp. 349-354

  2. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies

    British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550

1999

  1. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: Results of the Spanish National Donor Registry

    Bone Marrow Transplantation, Vol. 24, Núm. 7, pp. 723-728

1998

  1. Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry

    Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140

1997

  1. Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 25, Núm. 3-4, pp. 365-372

  2. Trasplante alogénico de progenitores hemopoyéticos de sangre periférica no manipulados: Experiencia española de 79 casos

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 42-43